Page last updated: 2024-09-02

caffeic acid phenethyl ester and guanabenz

caffeic acid phenethyl ester has been researched along with guanabenz in 1 studies

Compound Research Comparison

Studies
(caffeic acid phenethyl ester)
Trials
(caffeic acid phenethyl ester)
Recent Studies (post-2010)
(caffeic acid phenethyl ester)
Studies
(guanabenz)
Trials
(guanabenz)
Recent Studies (post-2010) (guanabenz)
84014694464296

Protein Interaction Comparison

ProteinTaxonomycaffeic acid phenethyl ester (IC50)guanabenz (IC50)
trace amine-associated receptor 1Homo sapiens (human)1.173
Solute carrier family 22 member 1 Homo sapiens (human)4.85
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)0.204
Alpha-2A adrenergic receptorHomo sapiens (human)0.041
Alpha-2B adrenergic receptorHomo sapiens (human)0.149
Alpha-2C adrenergic receptorHomo sapiens (human)1.106
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)2.068
Amine oxidase [flavin-containing] AHomo sapiens (human)1.787
Alpha-1D adrenergic receptorHomo sapiens (human)0.472
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.392
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.204
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)2.068
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.097

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbott, BM; Browne, EC1

Reviews

1 review(s) available for caffeic acid phenethyl ester and guanabenz

ArticleYear
Recent progress towards an effective treatment of amyotrophic lateral sclerosis using the SOD1 mouse model in a preclinical setting.
    European journal of medicinal chemistry, 2016, Oct-04, Volume: 121

    Topics: Amyotrophic Lateral Sclerosis; Animals; Biological Products; Disease Models, Animal; Drug Discovery; Humans; Mice; Superoxide Dismutase-1

2016